首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1081271篇
  免费   125894篇
  国内免费   1099篇
  1208264篇
  2016年   12492篇
  2015年   18586篇
  2014年   21686篇
  2013年   30068篇
  2012年   34474篇
  2011年   34828篇
  2010年   23537篇
  2009年   21952篇
  2008年   31503篇
  2007年   32415篇
  2006年   30514篇
  2005年   29178篇
  2004年   29172篇
  2003年   27782篇
  2002年   27085篇
  2001年   44652篇
  2000年   44965篇
  1999年   36296篇
  1998年   14262篇
  1997年   14747篇
  1996年   14115篇
  1995年   13375篇
  1994年   13058篇
  1993年   12902篇
  1992年   30886篇
  1991年   30136篇
  1990年   29790篇
  1989年   28890篇
  1988年   26681篇
  1987年   25926篇
  1986年   24054篇
  1985年   24186篇
  1984年   20121篇
  1983年   17607篇
  1982年   13907篇
  1981年   12503篇
  1980年   11812篇
  1979年   19372篇
  1978年   15729篇
  1977年   14237篇
  1976年   13421篇
  1975年   14821篇
  1974年   16086篇
  1973年   15769篇
  1972年   14190篇
  1971年   13166篇
  1970年   11234篇
  1969年   10749篇
  1968年   9670篇
  1967年   8758篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Several short-term mammalian test systems were used for mutagenicity testing of the organic solvent dichloromethane. The compound was negative in the forward mutation test on the HGPRT locus in Chinese hamster cells and the unscheduled DNA synthesis test in both human and hamster cells. In the test on DNA synthesis inhibition, dichloromethane caused an aspecific inhibition in both human and hamster cells, but in this test the effect did not indicate a DNA-damaging action. A weak positive effect was found in the test on sister-chromatid exchanges in hamster cells.  相似文献   
992.
993.
994.
995.
Nitracrine is used clinically as an antitumour agent, and analogues are actively being developed in some laboratories. The mutagenic activity of 9-[(3-dimethylaminopropyl)amino]-acridine and its 1-nitro (nitracrine), 2-, 3- and 4-nitro derivatives was evaluated at the 6-thioguanine and ouabain resistance loci in cultured Chinese hamster fibroblasts (V79-171b cell line). The des-nitro, 2- and 3-nitro caused no statistically significant mutagenic activity at either locus. Each of these 3 compounds weakly increased (approximately 2-fold) the incidence of micronuclei in the same cell line when tested at cytotoxic doses. Both the 1- and 4-nitro compounds increased the incidence of 6-thioguanine resistant cells from around 1 in 10(-6) to approximately 1 in 10(-4). The former compound significantly increased the frequency of ouabain-resistant cells. Both of these compounds were potent inducers of micronuclei in V79-171b cells, indicating high clastogenic activity. It would appear prudent to regard both of these compounds as potential human carcinogens.  相似文献   
996.
997.
998.
Two distinct rat propagates of a radiation leukemia virus (RadLV-Rs) from the C57BL mouse respectively induced characteristic leukemogenic effects. These were found to be related with the infection titers of the isolates, but not with either their antigenic specificities or their viral and proviral genome sequences.  相似文献   
999.
1000.
The shrinkage of yeast cells caused by high-pressure treatment (250 MPa, 15 min) was investigated using direct microscopic observation. A viable staining method after treatment allowed the volume variation of two populations to be distinguished: an irreversible volume decrease (about 35% of the initial volume) of pressure-inactivated cells during pressure holding time, and viable cells, which were less affected. A mass transfer was then induced during high-pressure treatment. Causes of this transfer seem to be related to a pressure-induced membrane permeabilization, allowing a subsequent leakage of internal solutes, where three ions (Na+, K+ and Ca2+), plus endogenous glycerol, were verified. This glycerol leakage was found to occur after yeast pressurization in a medium having low water activity, although the yeast was not inactivated. All these observations lead to the hypothesis that pressure-induced cell permeabilization could be the cause of yeast inactivation under pressure.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号